Edition:
United States

Aralez Pharmaceuticals Inc (ARLZ.OQ)

ARLZ.OQ on NASDAQ Stock Exchange Global Select Market

1.66USD
21 Feb 2018
Change (% chg)

$0.03 (+1.84%)
Prev Close
$1.63
Open
$1.65
Day's High
$1.67
Day's Low
$1.61
Volume
28,835
Avg. Vol
104,778
52-wk High
$4.65
52-wk Low
$0.95

Chart for

About

Aralez Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin,... (more)

Overall

Beta: --
Market Cap(Mil.): $109.02
Shares Outstanding(Mil.): 66.89
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.23 16.73
EPS (TTM): -- -- --
ROI: -- 14.02 35.60
ROE: -- 15.49 17.23

BRIEF-Aralez Pharmaceuticals files for mixed shelf offering of up to $100 mln - SEC filing‍​

* Aralez Pharmaceuticals Inc - files for mixed shelf offering of up to $100 million - SEC filing‍​ Source text: (http://bit.ly/2zrTHPn) Further company coverage:

Nov 09 2017

BRIEF-Aralez sees 2018 net revenues $140 mln to $160 mln‍​

* Aralez announces third quarter 2017 financial results and achieves profitability on an adjusted EBITDA basis for the first time in the third quarter

Nov 09 2017

Earnings vs. Estimates